578 results on '"Davis, Gary L."'
Search Results
2. Treatment of Chronic Hepatitis C Infection
3. Hepatitis C and G
4. Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants
5. Impact of Birth Cohort Screening for Hepatitis C
6. Natural History of Hepatitis C
7. Recurrent Hepatitis C After Transplantation
8. Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
9. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
10. Prospective Validity Study: CPI Work Orientation and Managerial Potential Scales.
11. Treatment Of Chronic Hepatitis C: Combination Therapy Permanently Eradicates The Virus In At Least 40% Of Patients
12. MMPI and CPI Scores of Child Molesters before and after Incarceration-for-Treatment.
13. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
14. Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy
15. Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C
16. A Charged Amino Acid Substitution within the Transmembrane Anchor of the Rous Sarcoma Virus Envelope Glycoprotein Affects Surface Expression but Not Intracellular Transport
17. HCV and Chemotherapy: Does Infection Change Management?
18. Effect of Interferon-α and Ribavirin Therapy on Serum GB Virus C/Hepatitis G Virus (GBV-C/HGV) RNA Levels in Patients Chronically Infected with Hepatitis C Virus and GBV-C/HGV
19. The Healthcare Burden Imposed by Liver Disease in Aging Baby Boomers
20. Hepatitis C Virus Infection—Pathobiology and Implications for New Therapeutic Options
21. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse
22. Treatment of chronic hepatitis C: Improved combination therapy
23. Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients
24. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
25. Epidemiology of Chronic HCV
26. Contributors
27. Hepatitis C
28. New Therapies: Oral Inhibitors and Immune Modulators
29. A yeast genetic assay for caspase cleavage of the amyloid-β precursor protein
30. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation
31. Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined
32. Economic model of a birth cohort screening program for hepatitis C virus
33. Treatment of chronic hepatitis C: Impact of combination therapy
34. A Randomized, Multicenter Study Comparing Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Recipients With Chronic Hepatitis C†
35. Assessment of Stress in Research and Clinical Settings
36. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
37. Long-Term Consequences After Jejunoileal Bypass for Morbid Obesity
38. MMPI Profiles of Liver and Heart Transplant Candidates With and Without Significant Histories of Heavy Alcohol Use
39. Inferior Vena Cava Stent Resolves Hepatopulmonary Syndrome in an Adult with a Spontaneous Inferior Vena Cava-Portal Vein Shunt
40. Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
41. Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease
42. Improved Results of Transplantation for Hepatocellular Carcinoma: A Report From the International Registry of Hepatic Tumors in Liver Transplantation
43. Poster Board #-Session: P232-I Survival and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma (Tumors Diagnosed before Transplantation) Are Improving.: Abstract# 889
44. Poster Board #-Session: P217-I Impact of Neoadjuvant Treatment of Hepatocellular Carcinoma on Survival after Liver Transplantation.: Abstract# 874
45. Post–liver transplant survival in hepatitis C patients is improving over time
46. Natural History of Hepatitis C
47. Contributors
48. Treatment of chronic hepatitis C infection: one step at a time
49. Activation of Tumor Necrosis Factor-α System in Chronic Hepatitis C Virus Infection
50. Modeling therapeutic benefit in the midst of uncertainty: Therapy for hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.